Click here to go to the previous page
Meeting the Operational Challenges of Risk-based Monitoring: Investigator and Sponsor Perspectives
Program Code:
328
Date:
Wednesday, June 26, 2013
Time:
10:15 AM to 11:45 AM
EST
CHAIR
:
Donna has over 20 years of experience in clinical research. Donna is President of DWD & Associates. She works with organizations in implementing clinical quality systems. She is an experience auditor and has expertise in SOP development for both investigator and sponsor organizations.
|
SPEAKER
(S):
Donna W. Dorozinsky, MSN,RN (SCHNON), President, DWD & Associates, Inc., United States
François Torche, (SPKNON), CEO, Cluepoints, United States
Amanda Julie Sax,
RN (SPKNON), Senior Director, Integrated Processes and Technologies,
Quintiles Transnational Corp., United States
Amanda Sax is Senior Director, Intregrated Processes and Technologies, Quintiles. She leads the development of Quintiles' approach to Risk-Based Monitoring, which optimises the clinical trial execution strategy for each trial to help customers manage risk and improve efficiency.
|
Description
This symposium will explore the changing regulatory landscape and novel approaches to risk-based monitoring. Risk-based monitoring puts new demands on the both the sponsor and investigator site. This symposium will offer solutions to meeting some of the many operational challenges of risk-based monitoring. It will also examine the impact of this guidance on the site from both the site perspective and the site monitoring perspective. It will also provide useful tips for successful site management and the identification of high quality sites that are prepared to thrive in this changing regulatory environment.